[May 25, 2016]

Animal Medication - Global Strategic Business Report - Key Players are Bayer HealthCare, Boehringer Ingelheim & Dechra Pharmaceuticals - Research and Markets

Research and Markets has announced the addition of the "Animal Medication - Global Strategic Business Report" report to their offering.

This report analyzes the worldwide markets for Animal Medication in US$ Million by the following End-Use Segments: Companion Animals, and Farm Animals. The Global market is further analyzed by the following Product Groups: Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2015 through 2022. The report profiles 113 companies includin many key and niche players such as -

• Bayer HealthCare AG
• Boehringer Ingelheim GmbH
• Ceva Santé Animale S.A
• Dechra Pharmaceuticals PLC
• Eli Lilly and Company

Key Topics Covered:

1. MARKET OUTLOOK

2. MARKET TRENDS & DYNAMICS

3. VETERINARY VACCINES MARKET

4. COMPETITIVE LANDSCAPE

5. PRODUCT OVERVIEW

6. PRODUCT LAUNCHES/APPROVALS

7. RECENT INDUSTRY ACTIVITY

8. FOCUS ON (News - Alert) SELECT GLOBAL PLAYERS

• Bayer HealthCare AG
• Boehringer Ingelheim GmbH
• Ceva Santé Animale S.A.
• Dechra Pharmaceuticals PLC
• Eli Lilly and Company
• Merck Animal Health
• Merial
• Vetericyn, Inc.
• Vétoquinol SA
• Virbac SA
• Zoetis, Inc.

9. GLOBAL MARKET PERSPECTIVE

For more information visit http://www.researchandmarkets.com/research/mvg52t/animal_medication

View source version on businesswire.com: http://www.businesswire.com/news/home/20160525006417/en/

[ Back To TMCnet.com's Homepage ]